JUNIPER PHARMACEUTICALS INC Finite-Lived Intangible Asset, Expected Amortization, Year Two
JUNIPER PHARMACEUTICALS INC had Finite-Lived Intangible Asset, Expected Amortization, Year Two of $256.00 thousand as of 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Notes › Intangible Assets › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo · last filed 2018-08-09
- 2018-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year Two $256.00K.
- 2018-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $272.00K.
- 2017-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Two $262.00K.
- 2017-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year Two $287.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Two |
|---|---|
| 2018-06-30 | $256.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $272.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $262.00K 10-K · filed 2018-03-09 |
| 2017-09-30 | $287.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | $279.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $268.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $265.00K 10-K · filed 2017-03-07 |
| 2016-09-30 | $303.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $313.00K 10-Q/A · filed 2016-11-14 |
| 2016-03-31 | $336.00K 10-Q · filed 2016-11-14 |
| 2015-12-31 | $346.00K 10-K/A · filed 2016-11-14 |
| 2015-09-30 | $447.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $463.00K 10-Q · filed 2015-08-04 |
| 2015-03-31 | $437.00K 10-Q · filed 2015-05-06 |
| 2014-12-31 | $458.00K 10-K · filed 2015-03-18 |
| 2014-09-30 | $527.00K 10-Q · filed 2014-10-31 |
| 2014-06-30 | $553.00K 10-Q · filed 2014-08-01 |
| 2014-03-31 | $540.00K 10-Q · filed 2014-05-02 |
| 2013-12-31 | $535.45K 10-K · filed 2014-03-05 |